Canada lags behind in H1N1 trials

Immunization to begin in November "if all goes well"

When it comes to kick-starting clinical trials of the new H1N1 vaccine, Canada is lagging behind the rest of the world, reports the Globe and Mail. During a teleconference earlier this week, federal chief health officer David Butler-Jones told reporters that GlaxoSmithKline has assured him that even though Canadian trials won’t begin until September or October, the company will have “all the information” that it needs by November, which is the target date for immunization to begin—”hopefully, if all goes well.” Trials are already underway in Australia, and the US plans to start its trials in the “near future.”

The Globe and Mail

Looking for more?

Get the Best of Maclean's sent straight to your inbox. Sign up for news, commentary and analysis.